Portal hypertension (PHT) in cirrhosis results from increased resistance to splanchnic blood
flow secondary to parenchymal and vascular changes within the liver. In an attempt to …

Since 1988, transjugular intrahepatic portosystemic shunt (TIPS) has been an effective
therapy for portal hypertension in many settings. Thanks to continuous technical …

Abstract Background The Freiburg index of post-TIPS survival (FIPS) score was recently
demonstrated to improve prediction of post-TIPS mortality relative to existing standards. As …

Abstract Background & Aims Bleeding from gastric fundal varices (isolated gastric varices
type 1/gastroesophageal varices type 2) represents a major problem because of a high …

Acute kidney injury (AKI) is common in cirrhotic patients affecting almost 20% of these
patients. While multiple etiologies can lead to AKI, pre-renal azotemia seems to be the most …

Emerging evidence and perspectives have pointed towards the heart playing an important
role in hepatorenal syndrome (HRS), outside of conventional understanding that liver …

Portal Vein Thrombosis (PVT), a common complication of advanced liver disease, is defined
as an obstruction of the portal vein due to thrombus formation that can extend to the superior …

End-stage liver disease (ESLD) is the culmination of progression of chronic liver disease to
cirrhosis, decompensation, and chronic liver failure, featuring portal hypertension or …

Background Esophagogastric variceal bleeding is a serious complication of decompensated
cirrhosis. Transjugular intrahepatic portal shunt (TIPS) is a salvage treatment with clear …

Objectives: Conventional transjugular intrahepatic portosystemic shunt (TIPS) stent insertion
is an established procedure with high rates of technical success. However, alternative …